Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.
Year founded2012
Served areaWorldwide
HeadquartersChemin des Aulx 12, 1228 Plan-les-Ouates – Switzerland
108,620,471
IPOJuly 13, 2018
Stock exchange(s)SIX Swiss Exchange